CN101049484A - Strong effective Chinese traditional medicine for treating lung cancer and other various cancers - Google Patents
Strong effective Chinese traditional medicine for treating lung cancer and other various cancers Download PDFInfo
- Publication number
- CN101049484A CN101049484A CNA200710106868XA CN200710106868A CN101049484A CN 101049484 A CN101049484 A CN 101049484A CN A200710106868X A CNA200710106868X A CN A200710106868XA CN 200710106868 A CN200710106868 A CN 200710106868A CN 101049484 A CN101049484 A CN 101049484A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- herba
- semen
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 31
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 11
- 201000005202 lung cancer Diseases 0.000 title abstract 2
- 208000020816 lung neoplasm Diseases 0.000 title abstract 2
- 210000000582 semen Anatomy 0.000 claims description 44
- 241000628997 Flos Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- 230000003389 potentiating effect Effects 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 241000255791 Bombyx Species 0.000 claims description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241000218176 Corydalis Species 0.000 claims description 5
- 241001489978 Eupolyphaga Species 0.000 claims description 5
- 239000004863 Frankincense Substances 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 5
- 241000124079 Mylabris Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 241001250596 Pleione Species 0.000 claims description 5
- 241000222640 Polyporus Species 0.000 claims description 5
- 241000195474 Sargassum Species 0.000 claims description 5
- 241000522620 Scorpio Species 0.000 claims description 5
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000009490 scorpio Substances 0.000 claims description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 5
- 239000000463 material Substances 0.000 abstract description 7
- 241001474374 Blennius Species 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000735234 Ligustrum Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 40
- 201000011510 cancer Diseases 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 17
- 239000000203 mixture Substances 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010010144 Completed suicide Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- DUWPGRAKHMEPCM-IZZDOVSWSA-N isobavachalcone Chemical compound CC(C)=CCC1=C(O)C=CC(C(=O)\C=C\C=2C=CC(O)=CC=2)=C1O DUWPGRAKHMEPCM-IZZDOVSWSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 2
- JQNVCUBPURTQPQ-UHFFFAOYSA-N (25R)-Inokosterone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(CO)C)CCC33O)C)C3=CC(=O)C21 JQNVCUBPURTQPQ-UHFFFAOYSA-N 0.000 description 2
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical group C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- JQNVCUBPURTQPQ-FTWMDKANSA-N Inokosterone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CC[C@H](CO)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 JQNVCUBPURTQPQ-FTWMDKANSA-N 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 229930003270 Vitamin B Chemical group 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 210000004404 adrenal cortex Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- OAUREGNZECGNQS-UHFFFAOYSA-N corylifolin Natural products O1C=2C=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=C(O)C=C1 OAUREGNZECGNQS-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- JQNVCUBPURTQPQ-XDWLXSIGSA-N inokosterone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(CO)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 JQNVCUBPURTQPQ-XDWLXSIGSA-N 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- SWDSVBNAMCDHTF-UHFFFAOYSA-N isowighteone Chemical compound C1=C(O)C(CC=C(C)C)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 SWDSVBNAMCDHTF-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical group 0.000 description 2
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Chemical group 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- XLSLFPQAPYONPW-WHUHBCJBSA-N (2s,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H](C#N)C1=CC=CC=C1 XLSLFPQAPYONPW-WHUHBCJBSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 1
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- PWAACAMQKVIVPZ-UHFFFAOYSA-N Corylin Natural products OC1=CC=C2C(=O)C(C3=CC=C4OC(C=CC4=C3)(C)C)=COC2=C1 PWAACAMQKVIVPZ-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- KYFBXCHUXFKMGQ-IBGZPJMESA-N Isobavachin Chemical compound C1([C@@H]2CC(=O)C=3C=CC(O)=C(C=3O2)CC=C(C)C)=CC=C(O)C=C1 KYFBXCHUXFKMGQ-IBGZPJMESA-N 0.000 description 1
- LMDXLPTZCSMMDJ-UHFFFAOYSA-N Isobavachin Natural products O1C=2C(CC=C(C)C)=C(O)C=CC=2CCC1C1=CC=C(O)C=C1 LMDXLPTZCSMMDJ-UHFFFAOYSA-N 0.000 description 1
- NRUOYYDQBWDRKE-UHFFFAOYSA-N Kanzonol D Natural products C1=C(O)C(CC=C(C)C)=CC(C=2OC3=CC(O)=CC=C3C(=O)C=2)=C1 NRUOYYDQBWDRKE-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- UNGXBWFICNLIRX-UHFFFAOYSA-N Laetrile Natural products NCC(OC1OC(C(O)C(O)C1O)C(=O)O)c2ccccc2 UNGXBWFICNLIRX-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GRTQKTZKFPAJMA-UHFFFAOYSA-N Neobavaisoflavone Natural products CC(C)=CCc1cc(c(O)cc1O)-c1coc2cc(O)ccc2c1=O GRTQKTZKFPAJMA-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- QGQMCLKYJMHDEZ-UHFFFAOYSA-N Polygonaquinone Natural products CCCCCCCCCCCCCCCCCCCCCC1=C(O)C(=O)C(C)=C(O)C1=O QGQMCLKYJMHDEZ-UHFFFAOYSA-N 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940118377 Vitamin antagonist Drugs 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 229940117895 bakuchiol Drugs 0.000 description 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SUULNAGREGMRMF-XYGWBWBKSA-N cyclohexyl-[2-[(z)-(9-hydroxy-10-methoxy-2,2,4-trimethyl-1h-chromeno[3,4-f]quinolin-5-ylidene)methyl]thiophen-3-yl]methanone Chemical compound C1=CC=2NC(C)(C)C=C(C)C=2C2=C1C=1C(OC)=C(O)C=CC=1O\C2=C/C=1SC=CC=1C(=O)C1CCCCC1 SUULNAGREGMRMF-XYGWBWBKSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000007775 late Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- OBGPEBYHGIUFBN-UHFFFAOYSA-N neobavaisoflavone Chemical compound C1=C(O)C(CC=C(C)C)=CC(C=2C(C3=CC=C(O)C=C3OC=2)=O)=C1 OBGPEBYHGIUFBN-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- GMFLGNRCCFYOKL-ACCCYTKYSA-N polypodine B Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@]21O GMFLGNRCCFYOKL-ACCCYTKYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- YHWNASRGLKJRJJ-UHFFFAOYSA-N sophoraflavanone B Natural products C1C(=O)C2=C(O)C(CC=C(C)C)=C(O)C=C2OC1C1=CC=C(O)C=C1 YHWNASRGLKJRJJ-UHFFFAOYSA-N 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An efficient Chinese medicine for treating lung cancer and other cancers is prepared from 5 Chinese-medicinal materials including oyster shell, seaweed, leech, lucid ligustrum fruit, etc.
Description
The present invention relates to cancer patient's medicine for treatment, especially a kind of potent Chinese medicine for the treatment of pulmonary carcinoma and other various cancers.
Cancer is still global difficult medical problem.All be difficult to cure because the clinical specificity of cancer patient, Western medicine still are Chinese medicine, and the obvious effective rate of treatment is extremely low.Up to the present, also there is not a kind of potent Chinese medicine for the treatment of pulmonary carcinoma and other various cancers.
Purpose of the present invention just provides a kind of potent Chinese medicine for the treatment of pulmonary carcinoma and other various cancers, is used for the treatment of pulmonary carcinoma and other various cancers, reaches the therapeutic effect and the purpose of various cancers and other metastatic cancer.The present invention is achieved like this: a kind of potent Chinese medicine for the treatment of pulmonary carcinoma and other various cancers, it is to be raw material by 89 kinds of Chinese medicines, formulated by a certain percentage, its constituent content proportioning is: Concha Ostreae 1.0~30%, Rhizoma Curcumae 0.1~30%, Herba Hedyotidis Diffusae 0.1~80%, Spica Prunellae 0.1~20%, Herba Houttuyniae 0.1~40%, Radix Asteris 0.1~40%, Semen Vaccariae 0.1~30%, rhizoma sparganic 0.1~20%, Thallus Laminariae (Thallus Eckloniae) 0.1~50%, Radix Curcumae 0.1~50%, Herba Cirsii 0.5~30%, Bulbus Fritillariae Uninbracteatae 0.1~50%, Spina Gleditsiae 0.2~1 0%, Radix Sophorae Tonkinensis 0.1~80%, Semen Lepidii (Semen Descurainiae) 0.1~50%, Semen Armeniacae Amarum 0.1~50%, stir-baked SQUAMA MANITIS 0.1~80%, Radix Notoginseng 0.1~60%, Herba Patriniae 0.1~60%, Cortex Mori 0.1~30%, Flos Chrysanthemi 0.1~60%, Radix Glehniae 0.1~30%, Radix Glycyrrhizae 0.1~20%, Hirudo 0.1~80%, Mylabris 0.1~20%, Periostracum Serpentis 0.1~60%, Eupolyphaga Seu Steleophaga 0.1-80%, Scorpio 0.1~80%, Pheretima 0.1~80%, Pseudobulbus cremastrae seu pleiones 0.1~80%, Radix Ginseng 0.1-40%, Radix Astragali 0.1-50%, Radix Codonopsis 0.1~50%, Herba Taraxaci 0.1~80%, Radix Cynanchi Atrati 0.1~80%, Herba Violae 0.1-20%, the Rhizoma Atractylodis Macrocephalae 0.1~20%, Rhizoma Coptidis 0.1~20%, Herba Portulacae 0.1~30%, the Radix Stemonae 0.1~20%, Radix Rehmanniae Preparata 0.1~20%, the Rhizoma Anemarrhenae 0.1~30%, Rhizoma Cimicifugae 0.1~20%, Radix Bupleuri 0.1~20%, Radix Stephaniae Tetrandrae 0.1-20%, Flos Carthami 0.1~30%, Rhizoma Chuanxiong 0.1~50%, Herba Asari 0.1~20%, Fructus Ligustri Lucidi 0.1-40%, Semen Strychni 0.1~40%, Caulis Spatholobi 0.1~80%, Fructus Cnidii 0.1~80%, Herba Scutellariae Barbatae 0.1~60%, Polyporus 0.1~30%, Radix Et Rhizoma Rhei 0.1~40%, Fructus Aurantii Immaturus 0.1~40%, Rhizoma Paridis 0.1~80% Sargassum 0.1-80%, Pericarpium Arecae 0.1-30%, Herba Solani Lyrati 0.1-80%, Rhizoma Corydalis 0.1~60%, Semen Coicis 0.1-60%, Semen Pharbitidis 0.1~40%, Herba Solani Nigri 0.1~80%, Radix Aconiti Lateralis Preparata 0.1-~20%, Cortex Cinnamomi 0.1~30%, Fructus Schisandrae Chinensis 0.1~30%, Rhizoma Dioscoreae Bulbiferae 0.1~80%, Radix Paeoniae Alba 0.1-40%, Halloysitum Rubrum 0.1~30%, Radix Morindae Officinalis 0.1~60%, Fructus Corni 0.1~80%, Radix Achyranthis Bidentatae 0.1~50%, the Cortex Eucommiae 0.1~50%, Rhizoma Smilacis Glabrae 0.1~80%, Radix Scutellariae 0.1~40%, Olibanum 0.1-60%, Myrrha 0.1~60%, Radix Rhodiolae 0.1~80%, Rhizoma Curcumae Longae 0.1~60%, Radix Aconiti 0.1~50%, Radix Angelicae Sinensis 0.1~40%, Bombyx Batryticatus 0.1~30%, Herba Ecliptae 0.1-40%, Fructus Litseae 0.1~80%, Semen Cuscutae 0.1~50%, Rhizoma Polygonati 0.1~80%, Carapax Trionycis 0.1-40%, Fructus Psoraleae 0.1-60%, wherein each crude drug sum by weight 100%.
The effect of some main components is:
The Radix Astragali---slightly warm in nature, sweet in the mouth.Function tonifying Qi and lifting yang, benefit are defended solid element, inducing diuresis to remove edema, expelling pus and toxin by strengthening QI, expelling pus and promoting granulation.Its composition contains cupreol, D-β-asparagine, astragalus polysaccharides, daucosterol, r-aminobutyric acid and several amino acids etc.In addition, still contain micro constitutent selenium.Astragalus polysaccharides can get multiple parts such as glucose and heteropolysaccharide after separating; has some immunologic enhancement; enhancing body is to the resistivity of various diseases; malignant tumor patient is taken for a long time; immunologic function is improved; the protection hemopoietic function of bone marrow alleviates behind the cancer patient radiotherapy and the caused side reaction of chemotherapy.Prove that according to pharmacological research Radix Astragali energy stimulating central nervous system strengthens reticuloendothelial system phagocytic activity; The effect that promotes organism metabolism is arranged, can strengthen cardiac contractile force, coronary artery dilator, renal blood vessels and whole body peripheral vessel bring high blood pressure down, and improve the cutaneous circulation effect.The Radix Astragali can also reduce the urine protein content of experimental nephritis, alleviates pathological state.In addition, still can the liver protecting, blood sugar lowering suppresses sweat gland secretion, adjusts endocrine, and certain antibacterial action is arranged, and the cancer patient is played the resistance against diseases of strengthening vital QI to eliminate pathogenic factors.
Rhizoma Polygonati---property is flat, and sweet in the mouth is gone into lung, spleen channel.Function: the spleen reinforcing lung moistening, supplementing QI and nourishing YIN promotes the production of body fluid, fatigue and asthenia.According to biochemical analysis, Rhizoma Polygonati contains phlegmatic temperament, polygonatum polysaccharide (by glucose, mannose, galacturonic acid be combined into), 11 seed amino acids such as Rhizoma Polygonati oligosaccharide (by glucose and fructose be combined into), lysine and polygonaquinone etc.Pharmacological research, Rhizoma Polygonati can bring high blood pressure down; The blood glucose that the inhibition epinephrine causes is too high; Prevent atherosclerosis and fatty infiltration of liver; Tubercule bacillus, Bacillus typhi, staphylococcus aureus, various skin fungus and adenovirus, skin ulcer exanthema virus all there is inhibitory action.The ability that indirect anticancer is arranged.
Radix Codonopsis---property is flat, sweet in the mouth.Invigorating the spleen and replenishing QI, is promoted the production of body fluid at spleen invigorating.Phytochemistry is analyzed, and its composition contains Saponin, inulin, fructose and micro-alkaloid, plant sterol etc.It is reported, still contain the pure acetas of Taraxacum terpene, wood inspection ketone, 17 seed amino acids, in 8 kinds of essential amino acids 7 kinds are wherein arranged, as lysine, threonine, valine, methionine, isoleucine, leucine and alanine etc., measure 14 kinds of inorganic elementss again, wherein K, Na, Ca, mg etc. are the macroelement of needed by human for 4 kinds.Fe, Cu, Zn, mn, Cr, mo etc. are the trace element of needed by human for 7 kinds.Radix Codonopsis has excitation to nervous system, and resistance that can enhancing body increases erythrocyte and hemoglobin, and to the leukopenia that X-ray therapy and chemistry cause it is raise, and brings high blood pressure down in addition and the effect of the blood glucose that raises.The effect that improves phagocytic function is arranged, promote lymphocyte transformation and inducement interferon, thereby play anticancer cancer suppressing action.
Cortex Cinnamomi---nature and flavor, suffering, sweet, hot.Return kidney, spleen, the heart, Liver Channel.Effect: it is supporing yang to mend fire, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow.Cortex Cinnamomi can be controlled all kinds of diseases and ailments.Supporting spirit and color is that all medicines are engaged earlier, and clothes of a specified duration are made light of one's life by commiting suicide not old, and the brilliance of looking unfamiliar is fawned on good normal as the boy." Mingyi Bielu " record, Cortex Cinnamomi has the effect of " promoting blood circulation is dredged deficiency for warming middle-JIAO, hard muscles and bones ".Shennong's Herbal is pointed out: " clothes are logical refreshing for a long time, and it is not old to make light of one's life by commiting suicide ".According to the pharmacology test, Cortex Cinnamomi contains volatile oil, is mainly cinnamic aldehyde, Cortex cinnamomi japonici (Ramulus Cinnamomi) acetic acid fat, Oleum Cinnamomi energy stimulating gastrointestinal road in the oil, and the facilitating digestion function is alleviated crampy gastrointestinal pain, gets rid of the digestive tract pneumatosis, strengthens blood circulation.Cortex Cinnamomi is the product of warming and recuperating the kidney-YANG, and anti-aging effects is arranged.Modern study proves that Cortex Cinnamomi energy adrenal cortex reinforcing hormonal action can strengthen nucleic acid metabolism, improve immunologic function, regulate immunologic balance effect and warming YANG and invigorate blood circulation, promote the QI and blood nucleus formation, can play the kidney gasification to the cancer patient, subsidy human body kidney qi strengthens cancer patient's resistance against diseases.
Radix Ginseng---warm in nature, sweet in the mouth, little hardship.Go into the heart, spleen, lung meridian.Effect: strongly invigorating primordial QI, strengthen the spleen and stomach, replenishing and restoring lung-QI, heart tonifying take off admittedly to calm the nerves and promote the production of body fluid.It is about 4% that composition contains total Saponin, and content is the mixture of Saponin more than 14 kinds than the main root height in the fibrous root.It is about 0.12% to contain volatile oil, and composition has β in the oil---elemene, Panaxynol and polyacetylene epoxy material panaxynol.In addition, still contain multiple low molecular peptide aminoacid, monosaccharide, disaccharidase, three polysaccharide, organic acid, vitamin B group, vitamin C, β---sitosterol, pharmacological research, Radix Ginseng can be strengthened corticocerebral process of excitation, simultaneously also can strengthen process of inhibition, improve the motility of neural activity process, increase work efficiency, reduce tired, can act on hypophysis and excited hypophysis---interrenal system, thereby enhancing body improves body to high temperature or cryogenic tolerance to the resistivity of destructive stimulus; The effect of the sex gland hormones of promotion sample is arranged, promote men and women's gonad function.Can regulate metabolism, blood sugar lowering suppresses the generation of high bile alcoholemia, and antidiuretic activity is arranged; Can strengthen cardiac contractile force, the blood pressure that slightly raises, and can promote hematopoietic function, can improve digestive and absorptive functions, appetite stimulator; Energy enhancing human body immunity function, the growth of radioprotective, anticancer.To the protein in brain, liver, cardiac muscle and the blood cell, ribonucleic acid (RNA), DNA (deoxyribonucleic acid) (DNA) and various enzyme material have the promotion anabolic effect especially.
The Rhizoma Atractylodis Macrocephalae---sweet in the mouth bitter, is warm in naturely gone into spleen, stomach warp.Effect: QI invigorating, spleen invigorating, dampness and in.The Rhizoma Atractylodis Macrocephalae contains volatile oil about 1.4%, and main component is an atractylone in the oil, and atractylol also contains vitamin A sample material.The Rhizoma Atractylodis Macrocephalae has the digestant effect of being good for the stomach, and effect in increasing leukocyte especially descends to the quantity of leucocyte that radiation and chemotherapy causes, the Rhizoma Atractylodis Macrocephalae can make it; Liver-protective effect is still arranged, can prevent that liver glycogen from reducing, and slight hypoglycemic activity is arranged; Can also strengthen hypophysis---adrenal cortex function and reticuloendothelial system function; Volatile oil also can suppress the animal tumor growth.The traditional Chinese medical science mainly dehumidifies in order to spleen benefiting and stimulating the appetite and spleen invigorating, and allocates in the invigorating the spleen and benefiting QI side as Qi-tonifying drug.The Rhizoma Atractylodis Macrocephalae still can strengthen the phagocytic function of reticuloendothelial system in addition, improves lymhocyte transformation rate and natural rosette formation rate, promotes cell immunocompetent, and obviously increases serum 1gG, and the prompting Rhizoma Atractylodis Macrocephalae has the effect of being good for the stomach, strengthening health and improving body resistance against diseases.The Rhizoma Atractylodis Macrocephalae also has obvious and persistent diuresis, is mainly used in the tumor growth effect that suppresses.
Radix Glycyrrhizae---property is flat, sweet in the mouth.With middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.Its plant chemical ingredient, contain the triterpenoid compound glycyrrhizin, it mainly is glycyrrhizic acid, glycyrrhizin has adsorption to poisonous substance, the glucuronic acid that produces after the hydrolysis can combine with poisonous substance, and glycyrrhizin also has the effect of adrenocortical hormone sample, and zoopery ulcers such as liquiritigenin and isoliquiritin unit have obvious inhibitory action, glycyrrhiza preparation treatment peptic ulcer has better curative effect.
Radix Glycyrrhizae, again for the panacea of annealing.Give birth to heat by bothering then empty.Deficiency-heat is from moving back with beneficial vigour for De Ganwen, and this component is a function of tumor inhibition.
Fructus Corni---sour and astringent Wen Ping.Liver and kidney tonifying, essence astringing and desertion stemming.Cure mainly: the logical nine orifices of settling five organs ends the normal urination water channel, and clothes make eye bright and keep fit for a long time.(in addition record) controls the brain osteodynia, treats tinnitus the kidney invigorating gas Xing Yangdao consolidating YIN convulsion and adds marrow and end old man's urine and do not save, and controls skin ulcer on the face, can diaphoresis to end month water indefinite, warm waist knee joint helps water dirty, removes a wind cutting, satisfies the broken knot that stagnates of all gas, warming the liver has indirect cancer suppressing action.
To be that the traditional Chinese medical science is commonly used set upright medicine to Fructus Ligustri Lucidi, and malignant tumor patient is taken this class for a long time and set upright medicine, and its immunologic function is improved, and the protection hemopoietic function of bone marrow alleviates behind the cancer patient radiotherapy and the caused side reaction of chemotherapy.Thereby have the raising immune function of human body, protect bone marrow and adrenal cortex function.
Radix Angelicae Sinensis is warm in nature, sweet in the mouth, suffering, go into liver, the heart, spleen three warps.Effect: enrich blood invigorate blood circulation, pain relieving, regulating menstruation is moisturized, loosening bowel to relieve constipation.Chemical analysis, Radix Angelicae Sinensis contain volatile oil, water-soluble alkaloid, sucrose, nicotinic acid, folic acid, vitamin B
12And vitamin E.Recent studies, Radix Angelicae Sinensis top head, middle part body, the bottom tip.Body is invigorated blood circulation, tip removing blood stasis, draw blood return through.Pharmacological research, Radix Angelicae Sinensis seemingly has " two tropisms " effect to the uterus, and its volatile oil can suppress uterus muscle, makes the uterus speed to delay; The water solublity involatile constituent then can excited uterus muscle, and uterine contraction is strengthened.Radix Angelicae Sinensis has the liver protecting, prevents the effect that liver glycogen reduces the cancer patient.Arrhythmia and the peripheral vascular effect of expansion are arranged, the effect that suppresses platelet aggregation is arranged, also have anti-inflammation and analgesic activity.
Radix Achyranthis Bidentatae-property is flat, bitter in the mouth, acid.Composition: contain Saponin and hydroxy ecdysterone (Ecdysterone), inokosterone (Inokosterone).Effect: the ripe tonifying liver and kidney and strengthening bones and muscles of using, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards.
The Cortex Eucommiae---sweet, warm.Return liver, kidney channel.Effect: invigorating the liver and kidney, bone and muscle strengthening, antiabortive, blood pressure lowering.Its composition still contains pectin, chlorogenic acid, organic acid, vitamin C, tannin and micro-alkaloid.The clinical practice deficiency of the liver and kindey, muscles and bones is unable, dizzy, sexual impotence, lower abdomen frequency, and the women suffers from a deficiency of the kidney, liability to abortion, soreness of waist fetal movement.The cancer patient there is kidney tonifying, improves the effect of health resistance against diseases.
Fructus Psoraleae-warm in nature, acrid in the mouth, hardship.Go into kidney, spleen channel.Function is mended fire from the gater of life, invigorating kidney-YANG, the warm therapeutic method to keep the adverse QI flowing downwards, controlling nocturnal emission with astringent drugs reducing urination, warming the spleen improving inspiration by invigorating kidney-QI antidiarrheal.The human body fire from the gater of life can help taste " digesting food ".The life fire is not enough if suffer from a deficiency of the kidney, and can not go up warming the spleen soil, so that fortuneization is unable, forms the diarrhea just before dawn of spleen-kidney vacuity cold.It is supporing yang that it can mend fire, the warming the spleen warming the kidney, and following two Jiao take in concurrently again and hold back astringent or styptic treatment for spontaneous sweating merit in kind the keeping.Chemical analysis, Fructus Psoraleae contain tonkabean analog derivative (psoralen, isopsoralene, psoralidine), flavone compound (Coryfolin, isobavachin, Fructus Psoraleae Class B, Coryfolin methyl ether, different Corylifolinin methyl ether, neobavaisoflavone, corylin), psoraldehyde, Bakuchiol, fatty oil and Saponin.Pharmacological research, Corylifolinin have obvious coronary artery dilator effect, and sarcoma-180 is had inhibitory action, and Fructus Psoraleae volatile oil has certain antitumaous effect, and psoralen (psoralen) can promote that skin pigment is new, the treatment vitiligo; Fructus Psoraleae has the effect of leukocyte increasing, can improve the phagocytic rate and the lymphocytic conversion ratio of macrophage, thereby improves the immunocompetence of body.Tubercule bacillus, staphylococcus and mycete there is inhibitory action.
Radix Rehmanniae Preparata-sweet in the mouth, slightly warm in nature.GUIXIN liver, kidney channel.Effect: nourishing YIN and benefiting blood, beneficial essence is filled out marrow.This product is the blood of reinforcing the heart liver both, and the spermatogenesis of nourishing kidney yin, and energy again benefit marrow is to being temperature compensation essence and blood, nourishing the liver and kidney, the key medicine of element culturing fixed folder.The ability that the cancer patient is had strengthening vital QI to eliminate pathogenic factors.Ingredient: iridoids contains 0.11% as catalpol approximately in the Radix Rehmanniae root; And contain stachyose 32.1%~48.3%; Several amino acids; Wherein the highest with arginine content, be 2-4.2%.Also isolate cupreol, mannitol and a small amount of stigmasterol, micro-campesterol.And contain rehmanin, alkaloid, retinoid material, various saccharides.The essentials of Matea Medica speech is " medicine on enriching blood ".All blood deficiency deficiencies, disease meeting color is sallow, dizzy, tinnitus, palpitation and insomnia, and women's blood deficiency, menoxenia, all cards of metrorrhagia, this product is key medicine.Pharmacological research, Radix Rehmanniae have blood sugar lowering, heart tonifying, hemostasis, diuresis and late effect property laxative action.In addition, also have hepatoprotective effect, can prevent the minimizing of liver glycogen.
Semen Cuscutae---property is flat, sweet in the mouth, suffering.Effect: invigorating the liver and kidney, beneficial marrow makes eye bright, and is antiabortive.Composition contains cholesterol, campesterol, β---sitosterol and triterpene acid.The effect that reduces the canceration risk factor is arranged.
Rhizoma Chuanxiong-warm in nature, acrid in the mouth, little if.Composition contains volatile oil 1%, and alkaloid has ligustrazine, L-isoleucyl--L valine acid anhydride etc.Phenols has the i.e. 4 hydroxyls-3-butylphthalide of chuanxingol, ferulic acid, chrysophanol, sedanoic acid, Palmic acid and Vanillyl aldehyde etc.Ligustrazine, its gas perfume (or spice) is strong, and tool has inhibitory action to multiple pathogenic bacteria and dermatophytes.The effect that also has vitamin antagonist E to lack, but thereby defying age.The traditional Chinese medical science is mainly used its blood-activating and qi-promoting, wind-expelling pain-stopping.Modern study, ligustrazine is used for angina pectoris, is mainly used in here and invigorates blood circulation, and draws all medicines and returns through going into blood system, and blood circulation promoting and blood stasis dispelling plays the effect of sensitizer.
Herba Asari-Xin Wen, expelling wind and cold, understand things pain-stopping, warming the lung to resolve fluid-retention, the medicine gesture priming of manageing it return through, go into edema caused by disorder of QI, help the medicine gesture, hard masses softening and resolving, function of promoting blood circulation to disperse blood clots.
Semen Armeniacae Amarum-contain laetrile has function of anti-skin aging, can keep people's youth appearance, and pair human lung's relieving cough and asthma is arranged, and lung moistening strengthens the ability of pulmonary function.
Herba Violae---cold in nature.Bitter in the mouth, suffering.The herb composition contains glycoside, flavonoid and wax.Effect: heat clearing away, detoxifcation, subduing inflammation has the effect that makes cancer cell-apoptosis.
Herba Taraxaci---cold in nature, bitter in the mouth, sweet.Return liver, stomach warp.The herb composition contains taraxasterol, choline, inulin and pectin.Effect: heat-clearing and toxic substances removing, the eliminating carbuncle eliminating stagnation, inducing diuresis for treating stranguria syndrome, anticancer effect.
Semen Coicis-abnormal smells from the patient, sweet, be slightly cold.Obey the QI invigorating of making light of one's life by commiting suicide for a long time.Cure mainly: muscular contracture contracture unable to flex and stretch the extremities, the lingering pathogenic wind arthralgia chiefly caused by damp pathogen therapeutic method to keep the adverse QI flowing downwards are obeyed the QI invigorating of making light of one's life by commiting suicide for a long time, control the consumptive lung disease lung qi, and wind prevailing over dampness consumer edema diuresis pyretic stranguria is removed in the invigorating spleen and reinforcing stomach heat clearing away.Modern study, Semen Coicis contains rich saccharide, albumen egg, vitamin B
1, Coixol and leucine, several amino acids such as arginine.Find that also coixenolide has inhibitory action to cancerous cell.So as preventing and treating gastric cancer, intestinal cancer, cervical cancer therapeutical effect is arranged all at present.
The present invention compared with prior art has following advantage:
1, the present invention is because the component decision belongs to pure Chinese medicinal preparation.
2, the present invention is because the component decision can reach and set upright the effect of getting rid of evils.
3, the present invention owing to the component decision, can improve the phagocytic activity of macrophage, promotes lymphocyte transformation and brings out interferon, thereby play anticancer and cancer suppressing action.
4, the present invention is because the component decision can reduce the canceration risk factor.
5, the present invention because cancerous cell can be directly or indirectly killed in the component decision, promotes the quick apoptosis of cancerous cell.
6, the present invention is because the component decision can make pulmonary carcinoma and other various treatment of cancer effects obvious, instant effect.
7, the present invention is because the component decision can make pulmonary carcinoma and various treatment of cancer effective percentage, obvious effective rate, clinical cure rate height.
8, the present invention is because the component decision belongs to the potent cancer Chinese medicine of controlling.
9, the present invention because the component decision can be played the effect of anti-chemicotherapy, makes the cancer patient of chemicotherapy, uses this medicine simultaneously, and therapeutic effect can be better.
10, the present invention is because the component decision has the potent analgesic effect of cancer.
11, the present invention because this medicine is used in the component decision, does not repel other medication.
12, the present invention is fit to industrialized great production, environmentally safe.
13, the present invention is fit to make the Chinese medicine preparation of various dosage forms.
14, low production cost of the present invention, Producer can obtain high added value.
15, the present invention will bring huge economic benefit to China.
16, the present invention will bring the huge social benefit to the whole world.
Embodiment (is radix with 1000 grams)
Provide embodiment:
1, Concha Ostreae 10g, Rhizoma Curcumae 20g, Herba Hedyotidis Diffusae 20g, Spica Prunellae 5g, Herba Houttuyniae 5g, Radix Asteris 5g, Semen Vaccariae 20g, rhizoma sparganic 10g, Thallus Laminariae (Thallus Eckloniae) 10g, Radix Curcumae 10g, Herba Cirsii 10g, Bulbus Fritillariae Uninbracteatae 10g, Spina Gleditsiae 20g, Radix Sophorae Tonkinensis 5g, Semen Lepidii (Semen Descurainiae) 10g, Semen Armeniacae Amarum 10g, stir-baked SQUAMA MANITIS 10g, Radix Notoginseng 20g, Herba Patriniae 10g, Cortex Mori 10g, Flos Chrysanthemi 5g, Radix Glehniae 5g, Radix Glycyrrhizae 5g, Hirudo 5g, Mylabris 5g%, Periostracum Serpentis 10g, Eupolyphaga Seu Steleophaga 5g, Scorpio 10g, Pheretima 5g, Pseudobulbus cremastrae seu pleiones 5g, Radix Ginseng 5g, Radix Astragali 5g, Radix Codonopsis 5g, Herba Taraxaci 20g, Radix Cynanchi Atrati 10g, Herba Violae 10g, Rhizoma Atractylodis Macrocephalae 5g, Rhizoma Coptidis 5g, Herba Portulacae 5g, Radix Stemonae 5g, Radix Rehmanniae Preparata 10g, Rhizoma Anemarrhenae 5g, Rhizoma Cimicifugae 5g, Radix Bupleuri 5g, Radix Stephaniae Tetrandrae 5g, Flos Carthami 10g, Rhizoma Chuanxiong 30g, Herba Asari 10g, Fructus Ligustri Lucidi 30g, Semen Strychni 5g, Caulis Spatholobi 5g, Fructus Cnidii 5g, Herba Scutellariae Barbatae 20g, Polyporus 5g, Radix Et Rhizoma Rhei 5g, Fructus Aurantii Immaturus 5g, Rhizoma Paridis 10g, Sargassum 10g, Pericarpium Arecae 5g, Herba Solani Lyrati 20g, Rhizoma Corydalis 10g, Semen Coicis 30g, Semen Pharbitidis 5g, Herba Solani Nigri 10g, Radix Aconiti Lateralis Preparata 5g, Cortex Cinnamomi 5g, Fructus Schisandrae Chinensis 5g, Rhizoma Dioscoreae Bulbiferae 20g, Radix Paeoniae Alba 5g, Halloysitum Rubrum 5g, Radix Morindae Officinalis 30g, Fructus Corni 30g, Radix Achyranthis Bidentatae 30g, Cortex Eucommiae 10g, Rhizoma Smilacis Glabrae 5g, Radix Scutellariae 20g, Olibanum 5g, Myrrha 5g, Radix Rhodiolae 10g, Rhizoma Curcumae Longae 10g, Radix Aconiti 5g, Radix Angelicae Sinensis 30g, Bombyx Batryticatus 5g, Herba Ecliptae 10g, Fructus Litseae 5g, Semen Cuscutae 10g, Rhizoma Polygonati 50g, Carapax Trionycis 20g, Fructus Psoraleae 30g.
2, Concha Ostreae 30g, Rhizoma Curcumae 10g, Herba Hedyotidis Diffusae 10g, Spica Prunellae 10g, Herba Houttuyniae 10g, Radix Asteris 5g, Semen Vaccariae 10g, rhizoma sparganic 5g, Thallus Laminariae (Thallus Eckloniae) 30g, Radix Curcumae 20g, Herba Cirsii 10g, Bulbus Fritillariae Uninbracteatae 10g, Spina Gleditsiae 20g, Radix Sophorae Tonkinensis 10g, Semen Lepidii (Semen Descurainiae) 10g, Semen Armeniacae Amarum 10g, stir-baked SQUAMA MANITIS 20g, Radix Notoginseng 20g, Herba Patriniae 20g, Cortex Mori 10g, Flos Chrysanthemi 10g, Radix Glehniae 15g, Radix Glycyrrhizae 10g, Hirudo 30g, Mylabris 10g, Periostracum Serpentis 10g, Eupolyphaga Seu Steleophaga 10g, Scorpio 30g, Pheretima 10g, Pseudobulbus cremastrae seu pleiones 20g, Radix Ginseng 30g, Radix Astragali 10g, Radix Codonopsis 10g, Herba Taraxaci 10g, Radix Cynanchi Atrati 5g, Herba Violae 5g, Rhizoma Atractylodis Macrocephalae 5g, Rhizoma Coptidis 5g, Herba Portulacae 5g, Radix Stemonae 10g, Radix Rehmanniae Preparata 10g, Rhizoma Anemarrhenae 10g%, Rhizoma Cimicifugae 5g, Radix Bupleuri 5g, Radix Stephaniae Tetrandrae 5g, Flos Carthami 5g, Rhizoma Chuanxiong 10g, Herba Asari 5g, Fructus Ligustri Lucidi 10g, Semen Strychni 10g, Caulis Spatholobi 10g, Fructus Cnidii 5g, Herba Scutellariae Barbatae 20g, Polyporus 5g, Radix Et Rhizoma Rhei 5g, Fructus Aurantii Immaturus 5g, Rhizoma Paridis 10g, Sargassum 10g, Pericarpium Arecae 20g, Herba Solani Lyrati 20g, Rhizoma Corydalis 10g, Semen Coicis 20g, Semen Pharbitidis 5g, Herba Solani Nigri 30g, Radix Aconiti Lateralis Preparata 5gh, Cortex Cinnamomi 5g, Fructus Schisandrae Chinensis 10g, Rhizoma Dioscoreae Bulbiferae 10g, Radix Paeoniae Alba 10g, Halloysitum Rubrum 10g, Radix Morindae Officinalis 10g, Fructus Corni 10g, Radix Achyranthis Bidentatae 5g, Cortex Eucommiae 5g, Rhizoma Smilacis Glabrae 10g, Radix Scutellariae 10g, Olibanum 5g, Myrrha 5g, Radix Rhodiolae 10g, Rhizoma Curcumae Longae 10g, Radix Aconiti 30g, Radix Angelicae Sinensis 10g, Bombyx Batryticatus 5g, Herba Ecliptae 10g, Fructus Litseae 5g, Semen Cuscutae 10g, Rhizoma Polygonati 10g, Carapax Trionycis 10g, Fructus Psoraleae 10g.
3, Concha Ostreae 10g, Rhizoma Curcumae 5g, Herba Hedyotidis Diffusae 5g, Spica Prunellae 15g, Herba Houttuyniae 10g, Radix Asteris 5g, Semen Vaccariae 20g, rhizoma sparganic 10g, Thallus Laminariae (Thallus Eckloniae) 10g, Radix Curcumae 10g, Herba Cirsii 10g, Bulbus Fritillariae Uninbracteatae 10g, Spina Gleditsiae 20g, Radix Sophorae Tonkinensis 10g, Semen Lepidii (Semen Descurainiae) 10g, Semen Armeniacae Amarum 10g, stir-baked SQUAMA MANITIS 10g, Radix Notoginseng 20g, Herba Patriniae 30g, Cortex Mori 5g, Flos Chrysanthemi 20g, Radix Glehniae 20g, Radix Glycyrrhizae 10g, Hirudo 10g, Mylabris 15g, Periostracum Serpentis 10g, Eupolyphaga Seu Steleophaga 10g, Scorpio 10g, Pheretima 10g, Pseudobulbus cremastrae seu pleiones 10g, Radix Ginseng 20g, Radix Astragali 5g, Radix Codonopsis 5g, Herba Taraxaci 10g, Radix Cynanchi Atrati 10g, Herba Violae 15g, Rhizoma Atractylodis Macrocephalae 5g, Rhizoma Coptidis 5g, Herba Portulacae 5g, Radix Stemonae 10g, Radix Rehmanniae Preparata 20g, Rhizoma Anemarrhenae 10g%, Rhizoma Cimicifugae 5g, Radix Bupleuri 5g, Radix Stephaniae Tetrandrae 5g, Flos Carthami 15g, Rhizoma Chuanxiong 5g, Herba Asari 5g, Fructus Ligustri Lucidi 10g, Semen Strychni 10g, Caulis Spatholobi 30g, Fructus Cnidii 5g, Herba Scutellariae Barbatae 20g, Polyporus 5g, Radix Et Rhizoma Rhei 5g, Fructus Aurantii Immaturus 5g, Rhizoma Paridis 30g, Sargassum 10g, Pericarpium Arecae 30g, Herba Solani Lyrati 20g, Rhizoma Corydalis 10g, Semen Coicis 10g, Semen Pharbitidis 5g, Herba Solani Nigri 20g, Radix Aconiti Lateralis Preparata 10g, Cortex Cinnamomi 30g, Fructus Schisandrae Chinensis 20g, Rhizoma Dioscoreae Bulbiferae 20g, Radix Paeoniae Alba 10g, Halloysitum Rubrum 5g, Radix Morindae Officinalis 5g, Fructus Corni 30g, Radix Achyranthis Bidentatae 5g, Cortex Eucommiae 5g, Rhizoma Smilacis Glabrae 5g, Radix Scutellariae 10g, Olibanum 5g, Myrrha 5g, Radix Rhodiolae 10g, Rhizoma Curcumae Longae 10g, Radix Aconiti 10g, Radix Angelicae Sinensis 10g, Bombyx Batryticatus 5g, Herba Ecliptae 5g, Fructus Litseae 5g, Semen Cuscutae 10g, Rhizoma Polygonati 5g, Carapax Trionycis 10g, Fructus Psoraleae 10g.
Embodiment not only is confined to above-mentioned, also desirable above-mentioned a certain embodiment:
1, the raw material of Chinese medicine dry body in the component is carried out quality screening, pick out unreasonable part such as go mouldy, make moist, damage by worms after, wash, adopt infrared ray or microwave drying, after the sterilization treatment that carries out disinfection, again each raw material is carried out ultra tiny direct processing and pulverizes.Press proportional quantity then, uniform mixing sieves, and the fill capsule is packed with blister packaging machine, and behind CO60 roentgenization sterilization, finished product packing dispatches from the factory.
2, above-mentioned a certain tcm components raw material drying body is carried out quality screening after, wash, soak after 2~4 hours, adopt prior art, extract, concentrate spray-dried again machine spray drying, powder process through concentration tank, after getting extraction material fill capsule, carry out blister package with blister packaging machine, after the sterilization of CO60 illumination-based disinfection, finished product packing dispatches from the factory.
3, can directly purchase the Chinese medicine intermediate feed, through proportioning, behind the mix homogeneously, directly behind filling machine fill capsule, carry out blister package after the sterilization of CO60 illumination-based disinfection with blister packaging machine, finished product packing dispatches from the factory.
4, also can be by the finished product material of processing technology (1,2,3), add the auxilliary material of an amount of dextrin after, spray-dried machine is made electuary, behind the tinfoil paper paper bag packing, behind the CO60 illumination-based disinfection, finished product packing dispatches from the factory.
Claims (1)
- A kind of potent Chinese medicine for the treatment of pulmonary carcinoma and other various cancers, it is characterized in that it is become by the following raw material medicines in percentage by weight medicine: Concha Ostreae 1.0~30%, Rhizoma Curcumae 0.1~30%, Herba Hedyotidis Diffusae 0.1~80%, Spica Prunellae 0.1~20%, Herba Houttuyniae 0.1~40%, Radix Asteris 0.1~40%, Semen Vaccariae 0.1~30%, rhizoma sparganic 0.1~20%, Thallus Laminariae (Thallus Eckloniae) 0.1~50%, Radix Curcumae 0.1~50%, Herba Cirsii 0.5~30%, Bulbus Fritillariae Uninbracteatae 0.1~50%, Spina Gleditsiae 0.2~10%, Radix Sophorae Tonkinensis 0.1~80%, Semen Lepidii (Semen Descurainiae) 0.1~50%, Semen Armeniacae Amarum 0.1~50%, stir-baked SQUAMA MANITIS 0.1~80%, Radix Notoginseng 0.1~60%, Herba Patriniae 0.1~60%, Cortex Mori 0.1~30%, Flos Chrysanthemi 0.1~60%, Radix Glehniae 0.1~30%, Radix Glycyrrhizae 0.1~20%, Hirudo 0.1~80%, Mylabris 0.1~20%, Periostracum Serpentis 0.1~60%, Eupolyphaga Seu Steleophaga 0.1~80%, Scorpio 0.1~80%, Pheretima 0.1~80%, Pseudobulbus cremastrae seu pleiones 0.1~80%, Radix Ginseng 0.1~40%, the Radix Astragali 0.1~50%, Radix Codonopsis 0.1~50%, Herba Taraxaci 0.1~80%, Radix Cynanchi Atrati 0.1~80%, Herba Violae 0.1~20%, the Rhizoma Atractylodis Macrocephalae 0.1~20%, Rhizoma Coptidis 0.1~20%, Herba Portulacae 0.1~30%, the Radix Stemonae 0.1~20%, Radix Rehmanniae Preparata 0.1~20%, the Rhizoma Anemarrhenae 0.1~30%, Rhizoma Cimicifugae 0.1~20%, Radix Bupleuri 0.1~20%, Radix Stephaniae Tetrandrae 0.1~20%, Flos Carthami 0.1~30%, Rhizoma Chuanxiong 0.1~50%, Herba Asari 0.1~20%, Fructus Ligustri Lucidi 0.1~40%, Semen Strychni 0.1~40%, Caulis Spatholobi 0.1~80%, Fructus Cnidii 0.1~80%, Herba Scutellariae Barbatae 0.1~60%, Polyporus 0.1~30%, Radix Et Rhizoma Rhei 0.1~40%, Fructus Aurantii Immaturus 0.1~40%, Rhizoma Paridis 0.1~80% Sargassum 0.1~80%, Pericarpium Arecae 0.1~30%, Herba Solani Lyrati 0.1~80%, Rhizoma Corydalis 0.1~60%, Semen Coicis 0.1~60%, Semen Pharbitidis 0.1~40%, Herba Solani Nigri 0.1~80%, Radix Aconiti Lateralis Preparata 0.1~20%, Cortex Cinnamomi 0.1~30%, Fructus Schisandrae Chinensis 0.1~30%, Rhizoma Dioscoreae Bulbiferae 0.1~80%, the Radix Paeoniae Alba 0.1~40%, Halloysitum Rubrum 0.1~30%, Radix Morindae Officinalis 0.1~60%, Fructus Corni 0.1~80%, Radix Achyranthis Bidentatae 0.1~50%, the Cortex Eucommiae 0.1~50%, Rhizoma Smilacis Glabrae 0.1~80%, Radix Scutellariae 0.1~40%, Olibanum 0.1~60%, Myrrha 0.1~60%, Radix Rhodiolae 0.1~80%, Rhizoma Curcumae Longae 0.1~60%, Radix Aconiti 0.1~50%, Radix Angelicae Sinensis 0.1~40%, Bombyx Batryticatus 0.1~30%, Herba Ecliptae 0.1~40%, Fructus Litseae 0.1~80%, Semen Cuscutae 0.1~50%, Rhizoma Polygonati 0.1~80%, Carapax Trionycis 0.1~40%, Fructus Psoraleae 0.1~60%, wherein each crude drug sum by weight 100%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200710106868XA CN101049484A (en) | 2007-05-14 | 2007-05-14 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200710106868XA CN101049484A (en) | 2007-05-14 | 2007-05-14 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101049484A true CN101049484A (en) | 2007-10-10 |
Family
ID=38781220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200710106868XA Pending CN101049484A (en) | 2007-05-14 | 2007-05-14 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101049484A (en) |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229343B (en) * | 2008-01-21 | 2010-04-21 | 封云祥 | Chinese traditional medicine for treating pulmonary tuberculosis |
CN101185717B (en) * | 2007-12-19 | 2010-06-02 | 吴作敬 | Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer |
CN101810826A (en) * | 2010-04-13 | 2010-08-25 | 邵梦扬 | Chinese medicament for treating liver cancer |
CN101703726B (en) * | 2009-11-19 | 2010-09-08 | 何玉伟 | Medicament for treating lung cancer |
CN101391036B (en) * | 2008-11-11 | 2010-12-08 | 李全国 | Medicine composition for treating lung cancer |
CN101375989B (en) * | 2008-09-27 | 2010-12-08 | 曹开镛 | Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof |
CN101954026A (en) * | 2009-07-15 | 2011-01-26 | 赵凤平 | Traditional Chinese medicine preparation for treating lung cancer and preparation method thereof |
CN102000263A (en) * | 2010-12-03 | 2011-04-06 | 陈陆敢 | Traditional Chinese medicine preparation for treating lung cancer |
CN102008563A (en) * | 2010-12-09 | 2011-04-13 | 湖南景民制药有限公司 | Anticancer traditional Chinese medicine and preparation method thereof |
CN101664536B (en) * | 2009-10-15 | 2011-04-20 | 赵金忠 | Traditional Chinese medicine composition for resisting tumors |
CN101698083B (en) * | 2009-10-23 | 2011-05-04 | 李季 | Medicament for preventing and treating lung cancer and preparation method thereof |
CN101700386B (en) * | 2009-11-12 | 2011-05-11 | 范先明 | Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
CN102078587A (en) * | 2010-11-23 | 2011-06-01 | 李子春 | High-efficiency tumor-eliminating pill |
CN101450165B (en) * | 2007-11-29 | 2011-06-29 | 北京九九方元保健品经销有限公司 | Anti-cancer traditional Chinese medicine compound ganoderma preparation and preparation method thereof |
CN102138991A (en) * | 2011-04-10 | 2011-08-03 | 王兴礼 | Pharmaceutical composition for treating oral cancer and skin cancer |
EP2353604A1 (en) * | 2010-02-03 | 2011-08-10 | Jong Hyun Nam | Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer |
CN101559199B (en) * | 2009-05-19 | 2011-09-07 | 曹桂景 | Chinese materia medica preparation for controlling tumor and adjunct tumor radiotherapy and chemotherapy and preparation method thereof |
CN102198239A (en) * | 2011-06-03 | 2011-09-28 | 李增英 | Medicament for treating cervical erosion |
CN102258595A (en) * | 2010-05-27 | 2011-11-30 | 李友林 | Traditional Chinese medicine composition for treating tuberculosis, preparation and application thereof |
CN102309656A (en) * | 2010-07-08 | 2012-01-11 | 上海中医药大学 | Chinese medicinal composition with effect of preventing and treating cancers and medicinal application of Chinese medicinal composition |
CN102327544A (en) * | 2008-10-24 | 2012-01-25 | 陶树发 | Traditional Chinese medicinal composition for treating cancer |
CN102397527A (en) * | 2010-09-19 | 2012-04-04 | 山东新时代药业有限公司 | Pharmaceutical composition and application thereof |
CN102441135A (en) * | 2010-10-09 | 2012-05-09 | 安徽科创中药天然药物研究所有限责任公司 | A Chinese medicinal composition for treating lung cancer and gastric cancer, and its preparation method and quality control technology |
CN102579873A (en) * | 2012-02-27 | 2012-07-18 | 林爱玲 | Traditional Chinese medicine for treatment of wind-warm syndrome and lung heat |
CN102579832A (en) * | 2012-03-23 | 2012-07-18 | 曾桂忠 | Traditional Chinese medicine for treating tumor |
CN102671140A (en) * | 2011-12-01 | 2012-09-19 | 成都地奥集团天府药业股份有限公司 | Anticancer traditional Chinese medicine combination oral liquid, preparation method and detection method thereof |
CN102988821A (en) * | 2012-10-23 | 2013-03-27 | 潘根起 | Chinese medicine composition for treating carcinomatosis postoperation, postchemotherapy and postradiotherapy and preparation method of Chinese medicine composition |
CN103041293A (en) * | 2012-11-29 | 2013-04-17 | 宁国市中医肿瘤医院 | Traditional Chinese medicine decoction for treating yin-deficiency internal-heat type lung cancer |
CN103083612A (en) * | 2011-11-07 | 2013-05-08 | 陕西方舟制药有限公司 | Traditional Chinese medicinal composition for treating cancers, and its preparation method |
CN101721513B (en) * | 2008-11-03 | 2013-11-06 | 南钟铉 | Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer |
CN103386056A (en) * | 2013-07-27 | 2013-11-13 | 郭香荣 | Anti-tumor traditional Chinese medicine troche and preparation method thereof |
CN103432401A (en) * | 2013-08-20 | 2013-12-11 | 梁世杰 | Traditional Chinese medicine powder prepared from three flowers, five seeds and six whites for treating lung cancer |
JP2014001248A (en) * | 2013-10-10 | 2014-01-09 | Kao Corp | Igfbp-5 expression inhibitor |
CN103550696A (en) * | 2013-11-01 | 2014-02-05 | 田静 | Medicine for treating lung cancer |
CN103550718A (en) * | 2013-11-18 | 2014-02-05 | 梁轶聪 | Traditional Chinese medicine composition for treating lung cancer |
JP2014028852A (en) * | 2013-10-10 | 2014-02-13 | Kao Corp | Igfbp-5 expression inhibitor |
CN103656461A (en) * | 2013-12-19 | 2014-03-26 | 王星月 | Traditional Chinese medicinal honeyed pill for treating gastric cancer and preparation method thereof |
CN103689786A (en) * | 2013-12-23 | 2014-04-02 | 孙斌 | Cigarette for treating toothache caused by external contraction of wind evil |
CN103735955A (en) * | 2013-12-14 | 2014-04-23 | 潘清水 | Medicine for treating lung cancer |
CN104258178A (en) * | 2014-08-28 | 2015-01-07 | 吕彦丽 | Medicine for treating lung cancer pleural effusion and preparation method of medicine |
CN104707101A (en) * | 2015-02-26 | 2015-06-17 | 天津大学 | Liver cancer and lung cancer resistant traditional Chinese medicine composition and application thereof |
US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
CN103611093B (en) * | 2013-12-11 | 2015-10-28 | 东莞市东卓中天生物科技有限公司 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
CN105770842A (en) * | 2016-05-16 | 2016-07-20 | 王顺 | Chinese patent medicine for treating cancer and preparation method of Chinese patent medicine |
CN105853704A (en) * | 2016-05-24 | 2016-08-17 | 王荔 | Medicine composition for treating tuberculosis |
CN105878325A (en) * | 2015-02-17 | 2016-08-24 | 涂翔 | Pharmaceutical composition for inhibiting tumor angiogenesis and preparation method of pharmaceutical composition |
CN105902885A (en) * | 2016-05-31 | 2016-08-31 | 汤曙光 | Traditional Chinese medicine for treatment of lung cancer |
CN106390037A (en) * | 2016-11-17 | 2017-02-15 | 佛山科学技术学院 | Traditional Chinese medicine capsule capable of reinforcing primordium and frittering away |
CN106421659A (en) * | 2016-11-17 | 2017-02-22 | 佛山科学技术学院 | Traditional Chinese medicine pills for enriching vitality and reducing consumption |
CN107551233A (en) * | 2017-01-20 | 2018-01-09 | 张继东 | A kind of Chinese medicinal capsule for treating lung tumors |
-
2007
- 2007-05-14 CN CNA200710106868XA patent/CN101049484A/en active Pending
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101450165B (en) * | 2007-11-29 | 2011-06-29 | 北京九九方元保健品经销有限公司 | Anti-cancer traditional Chinese medicine compound ganoderma preparation and preparation method thereof |
CN101185717B (en) * | 2007-12-19 | 2010-06-02 | 吴作敬 | Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer |
CN101229343B (en) * | 2008-01-21 | 2010-04-21 | 封云祥 | Chinese traditional medicine for treating pulmonary tuberculosis |
CN101375989B (en) * | 2008-09-27 | 2010-12-08 | 曹开镛 | Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof |
CN102327544A (en) * | 2008-10-24 | 2012-01-25 | 陶树发 | Traditional Chinese medicinal composition for treating cancer |
CN101721513B (en) * | 2008-11-03 | 2013-11-06 | 南钟铉 | Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer |
CN101391036B (en) * | 2008-11-11 | 2010-12-08 | 李全国 | Medicine composition for treating lung cancer |
CN101559199B (en) * | 2009-05-19 | 2011-09-07 | 曹桂景 | Chinese materia medica preparation for controlling tumor and adjunct tumor radiotherapy and chemotherapy and preparation method thereof |
CN101954026A (en) * | 2009-07-15 | 2011-01-26 | 赵凤平 | Traditional Chinese medicine preparation for treating lung cancer and preparation method thereof |
CN101664536B (en) * | 2009-10-15 | 2011-04-20 | 赵金忠 | Traditional Chinese medicine composition for resisting tumors |
CN101698083B (en) * | 2009-10-23 | 2011-05-04 | 李季 | Medicament for preventing and treating lung cancer and preparation method thereof |
CN101700386B (en) * | 2009-11-12 | 2011-05-11 | 范先明 | Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
CN101703726B (en) * | 2009-11-19 | 2010-09-08 | 何玉伟 | Medicament for treating lung cancer |
EP2353604A1 (en) * | 2010-02-03 | 2011-08-10 | Jong Hyun Nam | Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer |
CN101810826B (en) * | 2010-04-13 | 2012-01-11 | 邵梦扬 | Chinese medicament for treating liver cancer |
CN101810826A (en) * | 2010-04-13 | 2010-08-25 | 邵梦扬 | Chinese medicament for treating liver cancer |
CN102258595B (en) * | 2010-05-27 | 2013-04-24 | 李友林 | Traditional Chinese medicine composition for treating tuberculosis, preparation and application thereof |
CN102258595A (en) * | 2010-05-27 | 2011-11-30 | 李友林 | Traditional Chinese medicine composition for treating tuberculosis, preparation and application thereof |
CN102309656B (en) * | 2010-07-08 | 2014-04-09 | 上海中医药大学 | Traditional Chinese medicine composition with effect of preventing and treating cancers and medicinal application of traditional Chinese medicine composition |
CN102309656A (en) * | 2010-07-08 | 2012-01-11 | 上海中医药大学 | Chinese medicinal composition with effect of preventing and treating cancers and medicinal application of Chinese medicinal composition |
CN102397527B (en) * | 2010-09-19 | 2014-01-29 | 山东新时代药业有限公司 | Medicinal composition and application thereof |
CN102397527A (en) * | 2010-09-19 | 2012-04-04 | 山东新时代药业有限公司 | Pharmaceutical composition and application thereof |
CN102441135A (en) * | 2010-10-09 | 2012-05-09 | 安徽科创中药天然药物研究所有限责任公司 | A Chinese medicinal composition for treating lung cancer and gastric cancer, and its preparation method and quality control technology |
US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
CN102078587A (en) * | 2010-11-23 | 2011-06-01 | 李子春 | High-efficiency tumor-eliminating pill |
CN102000263A (en) * | 2010-12-03 | 2011-04-06 | 陈陆敢 | Traditional Chinese medicine preparation for treating lung cancer |
CN102008563A (en) * | 2010-12-09 | 2011-04-13 | 湖南景民制药有限公司 | Anticancer traditional Chinese medicine and preparation method thereof |
CN102138991B (en) * | 2011-04-10 | 2013-06-05 | 王兴礼 | Pharmaceutical composition for treating oral cancer and skin cancer |
CN102138991A (en) * | 2011-04-10 | 2011-08-03 | 王兴礼 | Pharmaceutical composition for treating oral cancer and skin cancer |
CN102198239B (en) * | 2011-06-03 | 2012-08-22 | 李增英 | Medicament for treating cervical erosion |
CN102198239A (en) * | 2011-06-03 | 2011-09-28 | 李增英 | Medicament for treating cervical erosion |
CN103083612A (en) * | 2011-11-07 | 2013-05-08 | 陕西方舟制药有限公司 | Traditional Chinese medicinal composition for treating cancers, and its preparation method |
CN102671140B (en) * | 2011-12-01 | 2013-03-06 | 成都地奥集团天府药业股份有限公司 | Anticancer traditional Chinese medicine combination oral liquid, preparation method and detection method thereof |
CN102671140A (en) * | 2011-12-01 | 2012-09-19 | 成都地奥集团天府药业股份有限公司 | Anticancer traditional Chinese medicine combination oral liquid, preparation method and detection method thereof |
CN102579873A (en) * | 2012-02-27 | 2012-07-18 | 林爱玲 | Traditional Chinese medicine for treatment of wind-warm syndrome and lung heat |
CN102579832A (en) * | 2012-03-23 | 2012-07-18 | 曾桂忠 | Traditional Chinese medicine for treating tumor |
CN102988821B (en) * | 2012-10-23 | 2015-04-22 | 潘根起 | Chinese medicine composition for treating carcinomatosis postoperation, postchemotherapy and postradiotherapy and preparation method of Chinese medicine composition |
CN102988821A (en) * | 2012-10-23 | 2013-03-27 | 潘根起 | Chinese medicine composition for treating carcinomatosis postoperation, postchemotherapy and postradiotherapy and preparation method of Chinese medicine composition |
CN103041293A (en) * | 2012-11-29 | 2013-04-17 | 宁国市中医肿瘤医院 | Traditional Chinese medicine decoction for treating yin-deficiency internal-heat type lung cancer |
CN103041293B (en) * | 2012-11-29 | 2014-04-09 | 宁国市中医肿瘤医院 | Traditional Chinese medicine decoction for treating yin-deficiency internal-heat type lung cancer |
CN103386056B (en) * | 2013-07-27 | 2014-11-26 | 刘颖 | Antitumor traditional Chinese medicine tablet and preparation method thereof |
CN103386056A (en) * | 2013-07-27 | 2013-11-13 | 郭香荣 | Anti-tumor traditional Chinese medicine troche and preparation method thereof |
CN103432401A (en) * | 2013-08-20 | 2013-12-11 | 梁世杰 | Traditional Chinese medicine powder prepared from three flowers, five seeds and six whites for treating lung cancer |
CN103432401B (en) * | 2013-08-20 | 2015-04-22 | 梁世杰 | Traditional Chinese medicine powder prepared from three flowers, five seeds and six whites for treating lung cancer |
JP2014028852A (en) * | 2013-10-10 | 2014-02-13 | Kao Corp | Igfbp-5 expression inhibitor |
JP2014001248A (en) * | 2013-10-10 | 2014-01-09 | Kao Corp | Igfbp-5 expression inhibitor |
CN103550696A (en) * | 2013-11-01 | 2014-02-05 | 田静 | Medicine for treating lung cancer |
CN103550696B (en) * | 2013-11-01 | 2015-07-08 | 崔斌 | Medicine for treating lung cancer |
CN103550718A (en) * | 2013-11-18 | 2014-02-05 | 梁轶聪 | Traditional Chinese medicine composition for treating lung cancer |
CN103611093B (en) * | 2013-12-11 | 2015-10-28 | 东莞市东卓中天生物科技有限公司 | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma |
CN103735955B (en) * | 2013-12-14 | 2016-04-13 | 潘清水 | The medicine for the treatment of pulmonary carcinoma |
CN103735955A (en) * | 2013-12-14 | 2014-04-23 | 潘清水 | Medicine for treating lung cancer |
CN103656461B (en) * | 2013-12-19 | 2015-11-04 | 余姚市吉佳电器有限公司 | A kind of Chinese medicine pill and preparation method for the treatment of gastric cancer |
CN103656461A (en) * | 2013-12-19 | 2014-03-26 | 王星月 | Traditional Chinese medicinal honeyed pill for treating gastric cancer and preparation method thereof |
CN103689786B (en) * | 2013-12-23 | 2015-08-26 | 赵健 | A kind of cigarette being used for the treatment of diseases caused by external factors wind-evil syndrome and having a toothache |
CN103689786A (en) * | 2013-12-23 | 2014-04-02 | 孙斌 | Cigarette for treating toothache caused by external contraction of wind evil |
CN104258178A (en) * | 2014-08-28 | 2015-01-07 | 吕彦丽 | Medicine for treating lung cancer pleural effusion and preparation method of medicine |
CN105878325A (en) * | 2015-02-17 | 2016-08-24 | 涂翔 | Pharmaceutical composition for inhibiting tumor angiogenesis and preparation method of pharmaceutical composition |
CN104707101A (en) * | 2015-02-26 | 2015-06-17 | 天津大学 | Liver cancer and lung cancer resistant traditional Chinese medicine composition and application thereof |
CN104707101B (en) * | 2015-02-26 | 2018-05-04 | 天津大学 | A kind of Traditional Chinese medicinal composition for treating lung cancer and liver cancer and purposes |
CN105770842A (en) * | 2016-05-16 | 2016-07-20 | 王顺 | Chinese patent medicine for treating cancer and preparation method of Chinese patent medicine |
CN105853704A (en) * | 2016-05-24 | 2016-08-17 | 王荔 | Medicine composition for treating tuberculosis |
CN105902885A (en) * | 2016-05-31 | 2016-08-31 | 汤曙光 | Traditional Chinese medicine for treatment of lung cancer |
CN106390037A (en) * | 2016-11-17 | 2017-02-15 | 佛山科学技术学院 | Traditional Chinese medicine capsule capable of reinforcing primordium and frittering away |
CN106421659A (en) * | 2016-11-17 | 2017-02-22 | 佛山科学技术学院 | Traditional Chinese medicine pills for enriching vitality and reducing consumption |
CN107551233A (en) * | 2017-01-20 | 2018-01-09 | 张继东 | A kind of Chinese medicinal capsule for treating lung tumors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101049484A (en) | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers | |
CN101642540B (en) | Chinese patent medicine for tranquilizing and allaying excitement | |
CN1170588A (en) | Pure natural plant human life energy nutritive substrate | |
CN101797326B (en) | Traditional Chinese medicine preparation for treating borborygmus diarrhea and preparation method thereof | |
CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
CN101773637A (en) | Broad-spectrum antiviral nano traditional Chinese medicine and preparation method thereof | |
CN104873947A (en) | Medicinal composition for treating dog acute upper gastrointestinal hemorrhage and preparation method thereof | |
CN103893722A (en) | Traditional Chinese medicinal composition for treating solar dermatitis and preparation method thereof | |
CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
CN1586317A (en) | Notifying soup material | |
CN102772737A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and fibrosis and preparation method thereof | |
CN101773655A (en) | Anti-AIDS nanometer Chinese medicine and production method thereof | |
CN100402081C (en) | Chinese patent medicine for treating gynaecologic disease and preparing method | |
CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
CN105267559B (en) | A kind of drug and preparation method thereof for treating diabete peripheral herve pathology | |
CN103330837B (en) | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis | |
CN102552708A (en) | Medicinal composition for calming liver wind | |
CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
CN105796685A (en) | Method for preparing traditional Chinese medicine composition for treating myocardial infarction | |
CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
CN101554426B (en) | Traditional Chinese medicine for treating diabetic obstipation | |
CN103028076A (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
CN103071125B (en) | Traditional Chinese medicament composition for treating endometriosis and preparation method thereof | |
CN1057465C (en) | Medicine for treating chronic kidney disease and its prepn. method | |
CN105998448A (en) | Method for preparing mulberry oral solution for improving immunity and oral solution prepared by same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Hao Laiqin Document name: Notification of Publication of the Application for Invention |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071010 |